What is the first line treatment for croup?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Treatment for Croup

Oral corticosteroids (specifically dexamethasone 0.15-0.6 mg/kg, maximum 10-12 mg as a single dose) are the first-line treatment for all cases of croup, regardless of severity. 1, 2, 3

Treatment Algorithm by Severity

Mild Croup

  • Administer oral dexamethasone 0.15-0.6 mg/kg (maximum 10-12 mg) as a single dose 1, 2
  • This is sufficient as monotherapy for mild cases 1
  • Observe for 2-3 hours to ensure symptoms are improving 4
  • No nebulized treatments are needed for mild disease 4

Moderate to Severe Croup

  • Give oral dexamethasone first, then add nebulized epinephrine (0.5 ml/kg of 1:1000 solution, maximum 5 ml) 1, 2, 4
  • Nebulized epinephrine provides rapid symptom relief but effects last only 1-2 hours 1, 2, 4
  • Patients must be observed for at least 2 hours after the last epinephrine dose to monitor for rebound symptoms 2, 4

Alternative Corticosteroid Options

  • Nebulized budesonide 2 mg is equally effective as oral dexamethasone when oral administration is not feasible 1, 5
  • Prednisolone 1-2 mg/kg (maximum 40 mg) can be used if dexamethasone is unavailable 2
  • Intramuscular dexamethasone 0.6 mg/kg is effective but oral route is preferred 5, 6

Hospitalization Criteria

Consider admission only after 3 doses of nebulized epinephrine are required - this updated threshold (rather than the traditional 2 doses) reduces hospitalizations by 37% without increasing revisits or readmissions 7, 1, 2

Additional admission criteria include:

  • Oxygen saturation <92% 1, 2
  • Age <18 months 1, 2
  • Respiratory rate >70 breaths/min 1, 2
  • Persistent difficulty breathing 1

Critical Pitfalls to Avoid

  • Never discharge a patient within 2 hours of nebulized epinephrine administration due to high risk of rebound airway obstruction 2, 4, 6
  • Never use nebulized epinephrine in outpatient settings where immediate return is not feasible 1, 2, 4
  • Do not withhold corticosteroids in mild cases - they benefit all severity levels 1, 4, 3
  • Avoid antibiotics as croup is viral in etiology 1, 8
  • Do not rely on humidified air or mist therapy - these lack evidence of benefit 2, 9, 3

Supportive Care

  • Administer oxygen to maintain saturation ≥94% if needed 1, 2
  • Use antipyretics for comfort 1, 2
  • Minimize handling to reduce oxygen requirements 1, 2
  • Ensure adequate hydration 2

Discharge Instructions

Discharge is appropriate when:

  • Stridor at rest has resolved 1, 4
  • Minimal or no respiratory distress present 1, 4
  • Adequate oral intake achieved 1, 4
  • Parents can recognize worsening symptoms and know to return if needed 1, 2, 4
  • Instruct parents to follow up with primary care if not improving after 48 hours 1, 2

References

Guideline

Treatment of Croup in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Croup in Toddlers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Croup: an overview.

American family physician, 2011

Guideline

Treatment of Croup with Nebulization

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Croup.

The Journal of family practice, 1993

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Current pharmacological options in the treatment of croup.

Expert opinion on pharmacotherapy, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.